Intervention Protocol

You have free access to this content

Advance care planning for haemodialysis patients

  1. Chi Eung Danforn Lim1,*,
  2. Suyi Siow2,
  3. Khai Ee Evelyn Ho3,
  4. Jia Lin Chua3,
  5. Nga Chong Lisa Cheng1,
  6. Cannas Kwok4,
  7. Frank Brennan5,
  8. Maria Cigolini6

Editorial Group: Cochrane Renal Group

Published Online: 13 SEP 2013

DOI: 10.1002/14651858.CD010737


How to Cite

Lim CED, Siow S, Ho KEE, Chua JL, Cheng NCL, Kwok C, Brennan F, Cigolini M. Advance care planning for haemodialysis patients (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 9. Art. No.: CD010737. DOI: 10.1002/14651858.CD010737.

Author Information

  1. 1

    University of New South Wales, South Western Sydney Clinical School, Faculty of Medicine, Blakehurst, New South Wales, Australia

  2. 2

    Faculty of Medicine, University of New South Wales, South Western Sydney Clinical School, Kensington, NSW, Australia

  3. 3

    Faculty of Medicine, University of New South Wales, Liverpool Hospital, South Western Sydney Clinical School, Liverpool, NSW, Australia

  4. 4

    University of Western Sydney, School of Nursing and Midwifery, Parramatta, NSW, Australia

  5. 5

    St George Hospital, Department of Renal Medicine, Kogarah, NSW, Australia

  6. 6

    Royal Prince Alfred Hospital, Department of Palliative Medicine, Camperdown, NSW, Australia

*Chi Eung Danforn Lim, South Western Sydney Clinical School, Faculty of Medicine, University of New South Wales, PO BOX 3256, Blakehurst, New South Wales, 2221, Australia. celim@unswalumni.com. D.LIM@UNSW.EDU.AU.

Publication History

  1. Publication Status: New
  2. Published Online: 13 SEP 2013

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The objective of this review is to determine whether advance care planning, compared with no or less structured forms of advance care planning, in haemodialysis patients can result in fewer hospital admissions or less use of treatments with life-prolonging or curative intent, and if patient's wishes were followed at end-of-life.